112 related articles for article (PubMed ID: 15191788)
1. Use of Magnetic Resonance Imaging for Visualization of Oral Dosage Forms in the Human Stomach: A Scoping Review.
Akbar T; Gershkovich P; Stamatopoulos K; Gowland PA; Stolnik S; Butler J; Marciani L
Mol Pharm; 2024 Apr; 21(4):1553-1562. PubMed ID: 38440796
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals.
Kararli TT
Biopharm Drug Dispos; 1995 Jul; 16(5):351-80. PubMed ID: 8527686
[TBL] [Abstract][Full Text] [Related]
3. Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state.
Mudie DM; Murray K; Hoad CL; Pritchard SE; Garnett MC; Amidon GL; Gowland PA; Spiller RC; Amidon GE; Marciani L
Mol Pharm; 2014 Sep; 11(9):3039-47. PubMed ID: 25115349
[TBL] [Abstract][Full Text] [Related]
4. PBPK models for the prediction of in vivo performance of oral dosage forms.
Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
[TBL] [Abstract][Full Text] [Related]
5. Measurements of rat and mouse gastrointestinal pH, fluid and lymphoid tissue, and implications for in-vivo experiments.
McConnell EL; Basit AW; Murdan S
J Pharm Pharmacol; 2008 Jan; 60(1):63-70. PubMed ID: 18088506
[TBL] [Abstract][Full Text] [Related]
6. Oral controlled-release formulation in veterinary medicine.
Lavy E; Steinman A; Soback S
Crit Rev Ther Drug Carrier Syst; 2006; 23(3):165-204. PubMed ID: 17206924
[TBL] [Abstract][Full Text] [Related]
7. Single-dose pharmacokinetics of telmisartan oral solution and effect of feeding in dogs.
Bechtel AG; Reinhart JM; Li Z
J Vet Pharmacol Ther; 2023 Jan; 46(1):17-24. PubMed ID: 36355449
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of isavuconazole in healthy cats after oral and intravenous administration.
Woerde DJ; Wittenburg LA; Dear JD
J Vet Intern Med; 2022 Jul; 36(4):1422-1429. PubMed ID: 35616184
[TBL] [Abstract][Full Text] [Related]
9. Development of a Novel Controlled-Release Tablet of Pregabalin: Formulation Variation and Pharmacokinetics in Dogs and Humans.
Kim KH; Lim SH; Shim CR; Park J; Song WH; Kwon MC; Lee JH; Park JS; Choi HG
Drug Des Devel Ther; 2020; 14():445-456. PubMed ID: 32099329
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of gabapentin in cats.
Adrian D; Papich MG; Baynes R; Stafford E; Lascelles BDX
J Vet Intern Med; 2018 Nov; 32(6):1996-2002. PubMed ID: 30307652
[TBL] [Abstract][Full Text] [Related]
11. Roux-en-Y duodenojejunostomy improves gastric emptying in experimental obstruction of the distal duodenum.
Mrowiec S; Jonderko K; Górka Z; Lampe P; Kasicka-Jonderko A; Kołodziejczak-Nalewajka J; Kuśnierz K; Olakowski M
PLoS One; 2018; 13(6):e0199759. PubMed ID: 29953549
[TBL] [Abstract][Full Text] [Related]
12. The effect of reducing energy density, via the addition of water to dry diet, on body weight and activity in dogs.
Alexander JE; Colyer A; Morris PJ
J Nutr Sci; 2017; 6():e42. PubMed ID: 29152246
[TBL] [Abstract][Full Text] [Related]
13. Biopharmaceutical Evaluation and CMC Aspects of Oral Modified Release Formulations.
Chang RK; Mathias N; Hussain MA
AAPS J; 2017 Sep; 19(5):1348-1358. PubMed ID: 28681160
[TBL] [Abstract][Full Text] [Related]
14. Exploring Canine-Human Differences in Product Performance. Part II: Use of Modeling and Simulation to Explore the Impact of Formulation on Ciprofloxacin In Vivo Absorption and Dissolution in Dogs.
Martinez MN; Mistry B; Lukacova V; Lentz KA; Polli JE; Hoag SW; Dowling T; Kona R; Fahmy RM
AAPS J; 2017 May; 19(3):712-726. PubMed ID: 28265981
[TBL] [Abstract][Full Text] [Related]
15. Disposition of Extended Release Levetiracetam in Normal Healthy Dogs After Single Oral Dosing.
Beasley MJ; Boothe DM
J Vet Intern Med; 2015; 29(5):1348-53. PubMed ID: 26290357
[TBL] [Abstract][Full Text] [Related]
16. Food Effect in Humans: Predicting the Risk Through In Vitro Dissolution and In Vivo Pharmacokinetic Models.
Mathias N; Xu Y; Vig B; Kestur U; Saari A; Crison J; Desai D; Vanarase A; Hussain M
AAPS J; 2015 Jul; 17(4):988-98. PubMed ID: 25933598
[TBL] [Abstract][Full Text] [Related]
17. In vivo performance of an oral MR matrix tablet formulation in the beagle dog in the fed and fasted state: assessment of mechanical weakness.
McInnes F; Clear N; Humphrey M; Stevens HN
Pharm Res; 2008 May; 25(5):1075-84. PubMed ID: 17917709
[TBL] [Abstract][Full Text] [Related]
18. Companion animal physiology and dosage form performance.
Sutton SC
Adv Drug Deliv Rev; 2004 Jun; 56(10):1383-98. PubMed ID: 15191788
[TBL] [Abstract][Full Text] [Related]
19. Oral delivery of medications to companion animals: palatability considerations.
Thombre AG
Adv Drug Deliv Rev; 2004 Jun; 56(10):1399-413. PubMed ID: 15191789
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
